When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PVCT - Provectus nabs fourth cancer combination therapy patent in U.S.
Provectus Biopharmaceuticals Inc
The USPTO has allowed Provectus' (OTC:PVCT) US patent application 15/804,357 for the combination of intratumoral PV-10 and systemic immunomodulatory therapy for the treatment of a range of solid tumor cancers.
More news on: Provectus Biopharmaceuticals, Inc., Healthcare stocks news,